Follow the 켐온 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 켐온 has published 1 reports. The latest transaction was disclosed on 12 October 2021 (Other). Among the most active insiders: 한국증권금융. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
KemOn is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.